Inhibitory effects of genistein in combination with gefitinib on the hepatocellular carcinoma Hep3B cell line

Combination therapy is an important method for treating advanced hepatocellular carcinoma (HCC). Gefitinib is an epidermal growth factor receptor (EGFR) inhibitor, which has profound effects on HCC. The purpose of the present study was to investigate the effects of genistein in combination with gefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Yongxi, Wang, Mingshan, Huang, Haijun, Zhang, Jiajie, Huang, Yicheng, Chen, Yingjun, Pan, Hongying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781792/
https://www.ncbi.nlm.nih.gov/pubmed/31611933
http://dx.doi.org/10.3892/etm.2019.8027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781792/
https://www.ncbi.nlm.nih.gov/pubmed/31611933
http://dx.doi.org/10.3892/etm.2019.8027

Ejemplares similares